Aging in Fabry Disease: Role of Telomere Length, Telomerase Activity, and Kidney Disease

Abstract

FD patients have significantly shorter LTL, but significantly higher TA compared to healthy controls. Increased TA activity in FD patients could be the compensation mechanism to prevent LTL decrease (and accelerated ageing), which seems to be exhausted at the advanced stage of renal disease.